HOP S. TRAN CAO to Carcinoma, Hepatocellular
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Carcinoma, Hepatocellular.
Connection Strength
2.083
-
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. 2024 Jun 03; 29(6):e803-e810.
Score: 0.466
-
Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.
Score: 0.442
-
Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 07; 25(7):758-765.
Score: 0.427
-
Benign hepatic incidentalomas. Curr Probl Surg. 2019 09; 56(9):100642.
Score: 0.328
-
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma. Oncology. 2025; 103(6):490-497.
Score: 0.119
-
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma. Oncology. 2023; 101(11):730-737.
Score: 0.110
-
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
Score: 0.092
-
Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
Score: 0.079
-
Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg. 2018 08; 268(2):303-310.
Score: 0.019